OMDA (Omada Health, Inc.) Projected Sales Volume

Omada Health, Inc. - graphic logo of issuer OMDA

Omada Health Inc develops digital therapeutics for hypertension and diabetes, combining coaching with gadgets to reduce employer costs. Revenue is based on contracts with insurance companies to implement preventive programs. The company's future sales projections help align the market price with the intrinsic value, while the 0.90 metric serves as the target level. Steady growth in corporate agreements fully covers current operating expenses.

OMDA - Omada Company Expected Sales Volume over the range 06/07/2025 - 11/16/2026

Analytical breakdowns for Omada Health Inc (OMDA)

- current price and projected stock value:
Summary company analysis:Omada Health
Signature product of Omada

The scalability of the Omada Health Inc (OMDA) digital platform within the B2B segment should be reflected in the dynamics of future sales volume, confirming the effectiveness of algorithm-driven care. This indicator compares expected revenue with the asset's market price to identify capital stagnation and hidden costs, allowing investors to recognize abnormal price stagnation despite growing operational metrics and avoid sudden losses.

Direct competitors

Company Future Sales Volume VEEV (Veeva)|Company Future Sales Doximity Corp|Company Projected Revenue HealthEquity Inc HQY|Company Future Revenue WAY|corvel.com - Projected Sales Volume|Company Future Revenue PRVA (Privia Health Group)|Huron Consulting (HURN) - Company Projected Revenue|CERT - Company Future Sales|OMCL (Omnicell Health) - Projected Sales Volume|Company Projected Revenue GDRX|Company Projected Revenue Schrodinger, Inc. (SDGR)|Company Future Sales Volume Phreesia PHR|Evolent Health, Inc. - Company Future Sales Volume|HSTM - Company Future Sales Volume|DH - Company Projected Revenue|Company Expected Sales Volume Consensus Cloud Solutions|AGL: Projected Sales Volume|Company Expected Sales Volume Absci (ABSI)|Company Future Sales Volume SY|Company Future Sales Volume nrchealth.com (NRC)|Company Projected Revenue Spok Holdings, Inc. (SPOK)|OPRX - Company Expected Sales Volume|Company Projected Revenue TruBridge, Inc. TBRG|Company Future Sales simulations-plus.com (SLP)|SOPHiA GENETICS SA - Projected Sales Volume|HCAT (Health Catalyst) - Company Revenue Forecast|CCLD: Projected Sales Volume|Research Solutions Inc. - Company Future Revenue|Company Projected Revenue DLH Holdings Corp.|Company Expected Sales Volume onemednet.com ONMD|Company Projected Revenue Scienture Holdings Inc. (SCNX)|Company Future Sales Volume Healthcare Triangle Corp HCTI|Company Projected Revenue iSpecimen Inc. ISPC|BFRG (Bullfrog AI Holdings) - Company Expected Revenue|WORX - Company Projected Revenue|Company Future Revenue MSPR (msprecovery.com)|ICCT (iCoreConnect Corp) - Company Future Sales Volume|MEDS: Company Projected Revenue Volume|Company Projected Revenue orgenesis.com|RCM: Company Future Revenue|Projected Sales Volume SHCR|streamlinehealth.net - Company Revenue Forecast|Projected Sales Volume SYRA (Syra Health Corporation)|Company Future Revenue AMEH|MODN: Company Future Sales Volume|NXGN (NextGen Healthcare Corp) - Company Revenue Forecast